Corteva (NYSE:CTVA) Stock Picked Up by Analysts at Barclays

Corteva logo with Materials background
Image from MarketBeat Media, LLC.

Key Points

  • Barclays initiated coverage of Corteva with an “equal weight” rating and an $11 price target, which the article says implies 31.5% upside from the current share price.
  • Analyst opinions are mixed: 14 analysts rate the stock a Buy, seven a Hold, and one a Sell; MarketBeat reports an overall “Moderate Buy” consensus.
  • CEO Luther C. Iv Kissam purchased 32,292 shares at an average price of $9.30, increasing his position by 21.09%.
  • Five stocks to consider instead of Corteva.

Equities researchers at Barclays began coverage on shares of Corteva (NYSE:CTVA - Get Free Report) in a report issued on Thursday, Benzinga reports. The brokerage set an "equal weight" rating and a $11.00 price target on the stock. Barclays's price objective would suggest a potential upside of 31.50% from the stock's current price.

A number of other equities research analysts have also commented on the company. KeyCorp decreased their price target on Corteva from $17.00 to $14.00 and set an "overweight" rating on the stock in a research report on Monday. New Street Research set a $17.00 price objective on Corteva in a research note on Monday, October 5th. Deutsche Bank restated a "buy" rating and set a $101.00 target price on shares of Corteva in a report on Monday, August 3rd. Morgan Stanley restated an "overweight" rating and issued a $18.00 price objective on shares of Corteva in a research report on Friday, October 2nd. Finally, UBS Group dropped their target price on Corteva from $15.00 to $10.00 and set a "neutral" rating for the company in a research report on Friday, November 13th. Fourteen investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $48.83.

Get Our Latest Report on CTVA

Corteva Stock Down 5.2%

Shares of NYSE CTVA opened at $8.37 on Thursday. The business has a fifty day moving average of $32.58 and a two-hundred day moving average of $68.60. The company has a debt-to-equity ratio of 0.14, a quick ratio of 1.08 and a current ratio of 1.56. Corteva has a 52-week low of $8.35 and a 52-week high of $90.97. The stock has a market cap of $5.58 billion, a PE ratio of 4.40, a PEG ratio of 1.26 and a beta of 0.58.

Insider Activity at Corteva

In other Corteva news, CEO Luther C. Iv Kissam bought 32,292 shares of Corteva stock in a transaction that occurred on Friday, November 13th. The stock was acquired at an average price of $9.30 per share, for a total transaction of $300,315.60. Following the completion of the acquisition, the chief executive officer owned 185,379 shares of the company's stock, valued at $1,724,024.70. This trade represents a 21.09% increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 0.15% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of CTVA. BlackRock Inc. acquired a new position in shares of Corteva during the 2nd quarter worth about $4,560,180,000. Wellington Management Group LLP lifted its position in shares of Corteva by 941.7% in the second quarter. Wellington Management Group LLP now owns 7,612,704 shares of the company's stock valued at $644,720,000 after buying an additional 6,881,875 shares during the last quarter. Royal Bank of Canada boosted its stake in shares of Corteva by 202.1% during the 1st quarter. Royal Bank of Canada now owns 7,458,624 shares of the company's stock worth $624,362,000 after acquiring an additional 4,989,371 shares during the period. Jupiter Topco LLC acquired a new position in shares of Corteva in the second quarter valued at $544,246,000. Finally, Bank of America Corp DE bought a new position in Corteva in the 2nd quarter valued at about $484,927,000. 81.54% of the stock is currently owned by institutional investors.

Corteva News Roundup

Investors following CTVA have been watching these news items:

  • Positive Sentiment: A Seeking Alpha article argues that Corteva’s Brazil-related challenges may eventually ease, suggesting potential for improvement, though this is an analyst view rather than a company announcement. Corteva: Brazil Issues Will Eventually Ease
  • Neutral Sentiment: Corteva reportedly completed a global seed business spin-off. The articles provided do not detail the financial terms or expected impact, so the effect on earnings and valuation is unclear. Corteva completes global seed business spin-off
  • Negative Sentiment: KeyCorp cut its earnings-per-share forecasts for fiscal 2026–2029: to $0.79, $0.75, $0.90 and $1.20, respectively. The analyst kept an Overweight rating and a $14 price target, but the lower estimates point to weaker expected earnings. KeyCorp lowers expectations for Corteva

Corteva Company Profile

(Get Free Report)

Corteva, Inc. is an agricultural science company that develops and supplies products and services for farmers. Its business focuses on seeds and crop protection, including technologies intended to help improve crop performance and manage weeds, insects, and plant diseases. Its seed portfolio includes corn, soybean, and other crop varieties, sold under brands such as Pioneer and Brevant. Corteva's crop protection offerings include herbicides, insecticides, fungicides, and biological products, alongside digital tools and services that support farm decision-making.

Featured Articles

Analyst Recommendations for Corteva (NYSE:CTVA)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Corteva Right Now?

Before you consider Corteva, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Corteva wasn't on the list.

While Corteva currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven. Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines